22 Jun 2023 12:47
Results of 2023 Annual General Meeting
Guildford, 22 June 2023: Ergomed plc (AIM: ERGO) ("Ergomed" or the "Company"), a company focused on providing specialised services to the pharmaceutical industry, announces the results of voting on the resolutions put to shareholders at its Annual General Meeting held earlier today. All resolutions were duly passed.
Details of the voting by way of a poll at the AGM in respect of each resolution are shown in the table below:
Resolution number | Resolution | Votes for | Votes against | Abstentions |
1 | Accounts | 39,697,194 | 912,240 | 81,986 |
2 | Reappoint auditor | 40,736,227 | 1,255 | 80 |
3 | Reappoint Anne Whitaker | 40,269,559 | 457,733 | 337 |
4 | Reappoint Jonathan Curtain | 40,607,611 | 129,614 | 337 |
5 | Reappoint Llew Keltner | 39,853,733 | 827,308 | 446 |
6 | Allot securities | 38,791,006 | 1,946,219 | 337 |
7 | Pre-emption rights | 38,049,052 | 2,498,173 | 190,337 |
8 | Pre-emption rights (acquisition) | 38,061,085 | 2,676,140 | 337 |
The full text of all resolutions can be found in the Notice of Annual General Meeting on the Company's website www.ergomedplc.com.
ENDS
Enquiries:
Ergomed plc | Tel: +44 (0) 1483 402 975 |
Miroslav Reljanović (Executive Chairman) | |
Jonathan Curtain (Chief Financial Officer) Keith Byrne (Senior Vice President, Capital Markets and Strategy)
| |
Numis Securities Limited (Nominated Adviser and Joint Broker) | Tel: +44 (0) 20 7260 1000 |
Freddie Barnfield / Euan Brown / Jack McLaren | |
Peel Hunt Securities Limited (Joint Broker) James Steel / Dr Christopher Golden |
Tel: +44 (0) 20 7418 8900
|
Consilium Strategic Communications -for UK enquiries | Tel: +44 (0) 20 3709 5700 |
Chris Gardner / Matthew Neal | ergomed@consilium-comms.com |
About Ergomed plc
Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand, a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO) and mission-critical regulatory compliance and consulting services under the ADAMAS brand. For further information, visit: http://ergomedplc.com.